Buprenorphine-induced hyperalgesia in the rat

European Journal of Pharmacology

Volumn 651, Issue 1-3, 2011, Pages 89-95

  Wala, Elzbieta P ^a   Holtman Jr , Joseph R ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antinociception; Buprenorphine; Hyperalgesia; NMDA receptor antagonist; Tolerance

Indexed keywords

BUPRENORPHINE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG TOLERANCE; EXPERIMENTAL MODEL; HYPERALGESIA; LOW DRUG DOSE; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; REPEATED DRUG DOSE; TAIL FLICK TEST;

ANALGESICS; ANIMALS; BUPRENORPHINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HYPERALGESIA; KETAMINE; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 78650677080     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.10.083     Document Type: Article

References (65)

1. R.M. Allen, A.L. Granger, and L. Dykstra The competitive N-methyl-D-aspartate receptor antagonist (-)-6-phosphonomethy-deca- hydroisoquiniline-3-carboxylic acid (LY235959) potentiates the antinociceptive effects of opioids that vary in efficacy at the mu-receptor J. Pharmacol. Ther. 307 2003 785 792
2. S. Ananthan Opioid ligands with mixed mu/delta opioid receptor interactions: an emerging approach to novel analgesics AAPS J. 8 1 2006 E118 E125
3. M.S. Angst, and J.D. Clark Opioid-induced hyperalgesia. A qualitative systemic review Anesthesiology 104 2006 570 587
4. M.S. Angst, W. Koppert, I. Pahl, D. Clark, and M. Schmelz Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal Pain 106 2003 49 57
5. A.K. Baker, L.H. Hoffmann, and T.F. Meert Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-agonists in mouse model of acute pain Pharmacol. Biochem. Behav. 74 2002 73 86
6. A.M. Beedle, J.E. McRory, O. Poirot, C.J. Doering, C. Altier, C. Barrere, J. Hamid, J. Nargeot, E. Bourinet, and G.W. Zamponi Agonist-independent modulation of N-calcium channels by ORL-1 receptors Nat. Neurosci. 7 2004 118 125
7. E.J. Bilski, C.E. Intrussi, W. Sadee, V.J. Hruby, and F. Porreca Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu- or delta-opioid agonists in mice Pain 68 1996 229 237
8. E. Celerier, J.P. Laulin, A. Larcher, L. Le Moal, and G. Simonnet Evidence for opiate-activates NMDA process masking opiate analgesia in rats Brain Res. 847 1999 18 25
9. E. Celerier, B.S. Rivat, Y. Jun, J.P. Laulin, A. Larcher, P. Reyner, and G. Simonnet Long lasting hyperalgesia induced by fentanyl in rats; preventive effect of ketamine Anesthesiology 92 2000 465 472
10. Celerier E., Laulin J.P., Corcuff J.B., Le Moal L., and Simonnet G. Progressive enhancement of delayed hyperalagesia induced by repeated heroin administration: a sensitization process J. Neurosci. 21 2001 4074 4080
11. T. Christoph, B. Kogel, K. Schiene, M. Meen, J. De Vry, and E. Friderichs Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain Eur. J. Pharmacol. 507 2005 87 98
12. L. Chu, M. Angst, and D. Clark Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations Clin. J. Pain 24 2008 479 496
13. S.M. Crain, and K.F. Shen Antagonists of excitatory opioid receptor function enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability Pain 84 2000 121 131
14. S.M. Crain, and K.F. Shen Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low naltrexone, unmasking potent opioid analgesia Brain Res. 888 2001 75 82
15. Z. Ding, and R.B. Raffa Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine Br. J. Pharmacol. 157 2009 831 843
16. 2+ channels in rats J. Neurosci. Res. 86 2008 471 479
17. R.M. Evans, H. You, S. Hameed, and C. Altier Heterodimerization of ORL1 and opioid receptors and its consequences for N-type calcium channels J. Biol. Chem. 285 2010 1032 1040
18. B.D. Fisher, and L.A. Dykstra Interactions between an N-methyl-D-aspartate antagonist and low-efficacy opioid receptor antagonists in assay of schedule-controlled responding and thermal nociception J. Pharmacol. Exp. Ther. 308 2006 130 1306
19. N. Galeotti, G.B. Stefano, M. Guarna, E. Bianchi, and C. Ghelardini Signaling pathway of morphine induced acute thermal hyperalgesia in mice Pain 123 2006 294 305
20. L.R. Gardell, R. Wang, S.E. Burgess, M.H. Ossipov, T.W. Vanderah, and T.P. Malan Jr. Sustained morphine exposure induces a spinal dynorphine-dependent enhancement of excitatory transmitter release from primary afferent fibers J. Neurosci. 22 2002 6747 6755
21. G. Grecksch, K. Bartzsch, A. Widera, A. Becker, V. Holt, and T. Koch Development of tolerance and sensitization to different opioid agonists in rats Psychopharmacology 186 2006 177 184
22. B. Guignard, A.E. Bossard, C. Coste, D.I. Sessler, C. Lebrault, P. Alfonsi, D. Flatcher, and M. Chauvin Intraoperative remifentanil increases postoperative pain and a morphine requirement Anesthesiology 93 2001 409 417
23. S.R. Hamman, and W.R. Martin Thermal evoked tail avoidance reflex; input-output relationship and their modulations Brain Res. Bull. 29 1992 507 509
24. G. Hans Buprenorphine: a review of its role in neuropathic pain J. Opioid Manage. 3 2007 195 206
25. Holtman J. Jr., and Wala E. Characterization of morphine-induced hyperalgesia in male and female rats Pain 114 2005 62 70
26. J.R. Holtman Jr., and E.P. Wala Characterization of the antinociceptive effect of oxycodone in male and female rats Pharmacol. Biochem. Behav. 83 2006 100 108
27. J.R. Holtman Jr., and E.P. Wala Characterization of the antinociceptive and pronociceptive effects of methadone in rats Anesthesiology 106 2007 563 571
28. J.R. Holtman Jr., X. Jing, and E.P. Wala Sex-related differences in the enhancement of morphine antinociception by NMDA receptor antagonists in rats Pharmacol. Biochem. Behav. 76 2003 285 293
29. J.R. Holtman Jr., P.A. Crooks, J. Johnson-Hardy, and E. Wala Interaction between morphine and norketamine enantiomers in rodent models of nociception Pharmacol. Biochem. Behav. 90 2008 769 777
30. S. Ide, M. Minami, M. Satoh, G.R. Uhi, I. Sora, and K. Ikeda Buprenorphine antinociception is abolished, but naloxone-senistive reward is retained, in mu-opioid receptor knockout mice Neuropharmacology 29 2004 1656 1663
31. A. Juni, G. Klein, and B. Kest Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems Brain Res. 1070 2006 35 44
32. A. Juni, G. Klein, J.E. Pintar, and B. Kest Nociception increases during opioid infusion in opioid receptor triple knock-out mice Neuroscience 147 2007 439 444
33. T.V. Khroyan, W.E. Polgar, F. Jiang, N.T. Zaveri, and L. Toll Nociceptin/orpharin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor antagonist J. Pharmacol. Ther. 331 2009 946 953
34. T. King, M.H. Ossipov, T.W. Vanderah, F.P. Porreca, and J. Lai Is paradoxical pain induced by sustained opioid exposure an underlying mechanism of opioid antinociceptive tolerance? Neurosignals 14 2005 194 205
35. W. Koppert, R. Sitti, K. Scheuber, M. Alsheimer, M. Schmeltz, and J. Scuttler Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidinre in humans Anesthesiology 99 2003 152 159
36. W. Koppert, H. Ihmsen, N. Korber, A. Wehrfritz, R. Sittl, M. Schmeltz, and J. Schuttler Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model Pain 118 2005 15 22
37. P.F. Kouya, J.H. Hao, and X.J. Hu Buprenorphine alleviates neuropathic pain-like behaviors in rats after spinal cord and peripheral nerve injury Eur. J. Pharmacol. 450 2002 49 53
38. J.P. Laulin, A. Larcher, E. Celerier, M. Le Moal, and G. Simonnet Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time Eur. J. Neurosci. 10 1998 782 785
39. J.P. Laulin, E. Celerier, A. Larcher, L.E. Le Moal, and G. Simonnet Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity Neuroscience 89 1999 631 636
40. J. Mao Mechanism of hyperalgesia and morphine tolerance: a current view of their possible interactions Pain 62 1995 259 274
41. J. Mao NMDA and opioid receptors; their interaction in antinociception, tolerance and neuroplasticity Brain Res. Rev. 30 1999 289 304
42. J. Mao Opioid-induced abnormal pain sensitivity: implication in clinical therapy Pain 100 2002 213 217
43. J. Mao Opioid-induced abnormal pain sensitivity Curr. Pain Headache 10 2006 67 70
44. J. Mao, B. Sung, R.R. Ji, and G. Lin Chronic morphine induces down-regulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity J. Neurosci. 22 2002 8312 8323
45. B. McNaull, T. Trang, M. Sutak, and K. Jhamandas Inhibition of tolerance to spinal morphine antinociception by low doses of opioid receptor antagonists Eur. J. Pharmacol. 10 2007 132 141
46. I.A. Mendez, and K.A. Trujillo NMDA receptor antagonists inhibit opiate antinociceptive tolerance and locomotor sensitization in rats Psychopharmacology 196 2008 497 509
47. 6 glioma cells: identification of non-peptide delta-inverse agonists Br. J. Pharmacol. 128 1999 556 562
48. M. Ohtani Basic pharmacology of buprenorphine Eur. J. Pain 1 2007 60 73
49. M. Ossipov, J. Lai, T. King, T. Vanderah, and F. Porreca Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure Biopolimers (Pept. Sci.) 80 2005 319 324
50. C.G. Pick, Y. Peter, S. Schreiber, and R. Weizman Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kapp a3 analgesia Brain Res. 744 1997 41 46
51. R.B. Raffa, and Z. Ding Examination of the preclinical antinociceptive efficacy of buprenorphine and its designation as full- or partial-agonist Acute Pain 9 2007 145 152
52. J.V. Roughan, and P.A. Flecknell Buprenorphine: a reappraisal of its antinociceptive effects and therapeutic use in alleviating post-operative pain in animals Lab. Anim. 36 2002 322 343
53. R. Ruscheweyh, and J. Sandkuhler Opioid and central sensitization: induction and reversal of hyperalgesia Eur. J. Pain 9 2005 149 152
54. Sandkuhler J., Benrath J., Brechtel C., Ruscheweyh R., and Heinke B. Synaptic mechanism of hyperalgesia Sandkuhler J. Bromm B. Gebhart G.F. Progress in Brain Research vol. 129 2000 Elsevier Science B.V. 81 100
55. N. Shimoyama, M. Shimoyama, C.E. Intrussi, and K.J. Elliot Ketamine attenuates and reverses morphine tolerance in rodents Anesthesiology 85 1996 357 366
56. G. Simonnet Pain opioids; from analgesia to anti-hyperalgesia? Pain 118 2005 8 9
57. G. Simonnet, and C. Rivat Opioid-induced hyperalgesia: abnormal or normal pain? NeuroReport 14 2003 1 7
58. Tejwani G.A., and Rattan A.K. The role of spinal opioid receptors in antinociceptive effects produced by intrathecal administration of hydromorphone and buprenorphine in the rats Anesth. Analg. 94 2002 1542 1546
59. K.A. Truillo, and H. Akil Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist, MK-801 Science 251 1991 85 87
60. E.L. Van Dorp, B. Kest, W.J. Kowalczyk, A.M. Morariu, A.M. Waxman, C.A. Arout, A. Dahan, and E.Y. Sarton Morphine-6-β-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans Anesthesiology 110 2009 1356 1363
61. A.C. Van Elstraete, P. Sitbon, F. Trabold, J.X. Mazoti, and D. Benhamou A single dose of intrathecal morphine in rat induces long-lasting hyperalgesia: the protective effect of prior administration of ketamine Anesth. Analg. 101 2005 1750 1756
62. T.W. Vanderah, M.H. Ossipov, J. Lai, T.P. Malan Jr., and F. Porreca Mechanism of opioid-induced pain and antinociceptive tolerance; descending facilitation and spinal dynorphin Pain 92 2001 5 9 (Pubitemid 32367931)
63. E.A. Walker, and A.M. Young Differential tolerance to antinociceptive effects of mu opioids during repeated treatment with etonitazene, morphine or buprenorphine in rats Psychopharmacology 154 2001 131 142
64. Walsh S.L., and Eisenberg T. The clinical pharmacology of buprenorphine: extrapolating from laboratory to the clinic Drug Alcohol Depend. 70 2003 S13 S27 (supplement)
65. A.R. Waxman, C. Arout, M. Caldwell, A. Dahan, and B. Kest Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice Neurosci. Lett. 46 2009 68 72